ResearcherCapital Medical UniversityActive in the last 2 years

Xu Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7488-963X; OpenAlex author ID A5027054401. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study. Co-author DOI 10.1016/j.ejrad.2025.112070 ↗
Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. Co-author DOI 10.1007/s00259-022-05954-y ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Min-Fu Yang · 1 shared paper, 2025 · strength 0.28
- Paper Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study. DOI 10.1016/j.ejrad.2025.112070 ↗
Ren Lang · 1 shared paper, 2025 · strength 0.28
- Paper Radiomics-based histological grading of pancreatic ductal adenocarcinoma using 18F-FDG PET/CT: A two-center study. DOI 10.1016/j.ejrad.2025.112070 ↗
Wenpeng Huang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Lei Kang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Cuicui Li · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Jigang Yang · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗
Qingfang Miao · 1 shared paper, 2022 · strength 0.14
- Paper Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models. DOI 10.1007/s00259-022-05954-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.